PATENT CLAIM ANALYSIS

Application Number: 15944193
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "158100"]

Abstract:
The present invention provides a therapeutic composition for prevention or treatment of neurodegenerative brain disease caused by traumatic brain injury, comprising a regulator increasing expression or activity of calcineurin, and a screening method for a therapeutic agent for traumatic brain injury and neurodegenerative brain disease mediated by tau protein.

Claim (Index 3):
The method according to  claim 1 , wherein the regulator increasing the activity of calcineurin is selected from the group consisting of compounds, peptides, peptide mimetics, aptamers, antibodies and natural products that are specifically binding to PPP3CA or PP2B.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.52941
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15503636', '14776924', '14324289', '10625986', '15424444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7466640572124102
- 35 USC 102 Novelty (BERT): 0.5297198638331556
- Combined Prediction Score: 0.7249696378744848
- Mean Citation Score: 292.59764600000005
- Max Citation Score: 332.16476
- Similarity Product: 226.91310698916908

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test